Literature DB >> 19075797

Toll like receptor - potential drug targets in infectious disease.

Francois Erard1, Bernhard Ryffel.   

Abstract

Toll like receptors (TLR) play a critical role in the recognition and response of pathogens by the innate immune system. Pathogen engagement of the TLR-MyD88 pathway favours the development of a protective Th1-biased T cell response. Interruption of TLR recognition or signalling has profound effects on innate immunity. Agonists or antagonists of specific TLRs modulate the host response to microbial infections and have effects beyond infectious control and may be used as immunostimulators in vaccine, cancer, inflammatory disorders and allergy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075797     DOI: 10.2174/187152608786734179

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  3 in total

1.  Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer.

Authors:  Wagner J Fávaro; Odilon S Nunes; Fabio Rf Seiva; Iseu S Nunes; Lisa K Woolhiser; Nelson Durán; Anne J Lenaerts
Journal:  Infect Agent Cancer       Date:  2012-06-18       Impact factor: 2.965

2.  Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis.

Authors:  Siyou Tan; Wenyan Chen; Hongxian Xiang; Gaoyin Kong; Lianhong Zou; Lai Wei
Journal:  Genes Genomics       Date:  2021-01-11       Impact factor: 1.839

3.  Streptococcus pneumoniae PepO promotes host anti-infection defense via autophagy in a Toll-like receptor 2/4 dependent manner.

Authors:  Zhaoche Shu; Jun Yuan; Hong Wang; Jinghui Zhang; Sijie Li; Hong Zhang; Yusi Liu; Yibing Yin; Xuemei Zhang
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.